Analysis
Norway’s new principles for primary prevention of cardiovascular disease: age differentiated risk thresholds
BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d3626 (Published 13 July 2011) Cite this as: BMJ 2011;343:d3626
Related articles
- Editor's Choice Published: 13 July 2011; BMJ 343 doi:10.1136/bmj.d4478
- Primary Care Published: 08 September 2005; BMJ 331 doi:10.1136/bmj.38555.648623.8F
- PRIMARY CARE Published: 15 August 2005; BMJ doi:10.1136/bmj.38555.648623.8F
- Education And Debate Published: 27 November 1999; BMJ 319 doi:10.1136/bmj.319.7222.1426
- Editorial Published: 19 July 2007; BMJ 335 doi:10.1136/bmj.39262.643090.47
- Correction Published: 20 July 2011; BMJ 343 doi:10.1136/bmj.d4666
- Letter Published: 10 August 2011; BMJ 343 doi:10.1136/bmj.d4913
See more
- Cardiovascular disease: Just one in 12 eligible people had health check last year, watchdog findsBMJ November 13, 2024, 387 q2518; DOI: https://doi.org/10.1136/bmj.q2518
- Semaglutide’s CVD indication could cost US Medicare $145bn extra a yearBMJ August 28, 2024, 386 q1878; DOI: https://doi.org/10.1136/bmj.q1878
- Semaglutide: UK regulator approves drug for prevention of cardiovascular eventsBMJ July 25, 2024, 386 q1660; DOI: https://doi.org/10.1136/bmj.q1660
- Why India is failing to track heatstroke fatalities properlyBMJ July 17, 2024, 386 q1437; DOI: https://doi.org/10.1136/bmj.q1437
- Mail on Sunday articles that accused three commentators of being “statin deniers” were misinformed, judge rulesBMJ June 26, 2024, 385 q1424; DOI: https://doi.org/10.1136/bmj.q1424
Cited by...
- Longitudinal cholesterol trends across socioeconomic groups in Norway: the influence of lipid-lowering drugs in the population-based Tromso Study 1994-2016
- Should identical CVD risks in young and old patients be managed identically? Results from two models
- Risk stratification could reduce costs in primary prevention of cardiovascular disease